Impact of a clinical pharmacy research team on pharmacy resident research

Kari L Olson1, Adriane N Irwin1, Sarah J Billups1

  • 1Kari L. Olson, Pharm.D., is Clinical Pharmacy Supervisor, Clinical Pharmacy Cardiac Risk Service, Pharmacy Department, Kaiser Permanente Colorado (KPCO), Aurora, and Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora. Adriane N. Irwin, M.S., Pharm.D., is Clinical Assistant Professor, Oregon State University College of Pharmacy, Corvallis; at the time of writing, she was Clinical Pharmacy Research Fellow, Pharmacy Department, KPCO. Sarah J. Billups, Pharm.D., is Clinical Pharmacy Specialist, Clinical Pharmacy Research Team (CPRT), Pharmacy Department, KPCO, and Clinical Assistant Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Thomas Delate, Ph.D., M.S., is Clinical Pharmacy Research Scientist, CPRT, Pharmacy Department, KPCO, and Clinical Instructor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Samuel G. Johnson, Pharm.D., is Clinical Pharmacy Specialist, Applied Pharmacogenomics, Pharmacy Department, KPCO, and Clinical Instructor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Deanna Kurz, Pharm.D., B.A., CCRP, is Senior Project Manager, CPRT, Pharmacy Department, KPCO. Daniel M. Witt, Pharm.D., FCCP, BCPS, is Professor (Clinical) and Vice Chair, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City; at the time of writing, he was Senior Manager, Clinical Pharmacy Research and Applied Pharmacogenomics, Department of Pharmacy, KPCO.

Abstract

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
955
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.1K